This website was discontinued on 20/12/2022. Visit the new website at

Skip nav

Joint Programming Neurodegenerative Disease

International Cooperation



On 20 November 2018 JPND announced a new ERA-NET Cofund project, JPcofuND2, established under the European framework programme for investigation and innovation H2020, which continues the work of the JPcofuND project (2014-2019) and other activities pursued by the European joint programming initiative on neurodegenerative diseases research (for more information please check JPND's page in FCT's website).

JPcofuND2 is implemented between 2019 and 2023, and its major activities are:

  • organising a call with both national and European funds (see below) and four additional calls without European funds;
  • communicating/disseminating activities and initiatives of JPcofuND 2 through two symposia;
  • monitoring and evaluating the impact of JPcofuND 2 actions.

The following countries are part of JPcofuND 2: France; Finland; Canada*; Israel; Germany; Portugal (FCT and Regional Fund for Science and Technology of the Azores); Austria; Luxembourg; Belgium; Ireland; Denmark; Spain; Czech Republic; Italy; Slovenia; United Kingdom; Poland; Hungary; Norway; Switzerland; Sweden; Turkey; Latvia; Netherlands. *does not receive EC funding

On this page you can consult information about JPcofuND 2, namely:

Joint calls in progress

JPND Call for Proposals:


  • Submission deadline for full proposals (only for proposals selected in the pre-proposal evaluation phase): June 28, 2022, 12:00h (noon) C.E.T.
  • Submission deadline for pre-proposals: March 1, 2022, 12:00h (noon) C.E.T.

2022 JPND Call for Proposals: Understanding the mechanisms of non-pharmacological interventions

Please check JPcofuND2's CTC 2022 call text for detailed information on participating countries, aim of the call, management, eligibility, funding regulation and application, among other relevant information.

For more information, please check call documentation, national documentation and relevant links in the yellow box on the right.

Call Topics

Proposals must focus on one or several of the following neurodegenerative diseases:

  • Alzheimer’s disease and other dementias
  • Parkinson’s disease and PD‐related disorders
  • Prion diseases
  • Motor neuron diseases
  • Huntington’s disease
  • Spinocerebellar ataxia (SCA)
  • Spinal muscular atrophy (SMA)

Participating Countries

See the list of participating countries on the JPcofuND2 CTC 2022 page.

How to Apply

  • Please check call documentation and national documentation available in the yellow box on the right.
  • Check the national or regional rules of the countries participating in your consortium (including Portuguese), available through the Country-specific information link. Partners that are considered non-eligible may result in the rejection of the entire consortium.
  • Complete the pre-proposal template and the proposal submission tool, available on the call page.
  • Up to 10 working days after the deadline for submission of pre-proposals, Portuguese teams (coordinators and/or partners) must send the following statement of commitment to the National Contact Point for the call, duly signed by the Researcher in Charge and by the legal representative of the Proposing Institution and stamped. The original must be kept, as it may be requested by the FCT.

Funding Commitment (Portugal only)

FCT's funding commitment for JPcofuND2's CTC 2022: €150,000.00 (one hundred and fifty thousand Euros).

Note: if more than one Portuguese institution participates in a given consortium, the budget has to be shared. Portuguese institutions must follow FCT's Legislation, Regulations and Norms. The dedication (FTE) in transnational projects is not taken into account for the 100% (FTE) dedication to national projects.

Applicable Regulation (Portugal only)

The regulation applicable to projects to be funded by FCT is the Regulation on Projects Funded Solely by National Funds.

Note: the information contained in this page does not exempt from reading the call text, nor the other documents related to the call or the application process, constituting only a summary of them. No information contained in this page replaces or supersedes what is stipulated in the call text, in its procedures or in any other document of the call presented in the webpage of the CTC 2022 of JPcofuND2.

National Contact Points

Alexandre Maurício (main national contact point)
T. (+351) 213 917 648

Marta Abrantes

Previous joint calls


JPcofuND2 Joint Transnational Call 2021 supported a number of ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that aimed at identifying and measuring physiological effects and related biomarkers that could be linked to the development of neurodegenerative diseases, as well as enhancing the understanding of causal underlying cellular, molecular, metabolic, inflammatory or other systemic processes.

Proposals focused on one or more of the following neurodegenerative diseases:

  • Alzheimer’s disease and other dementias
  • Parkinson’s disease and PD‐related disorders
  • Prion diseases
  • Motor neuron diseases
  • Huntington's disease
  • Spinocerebellar ataxia (SCA)
  • Spinal muscular atrophy (SMA)

Twenty-three national and regional agencies from JPND countries participated in the competition.

You can find more information about this contest on the call page on the JPND website.

Results and funding granted



For more information on this and other projects funded under the JPcofuND2 JTC 2021 please check the results of the call in the JPcofuND2 JTC 2021 results page.


Marta Abrantes
(Tel: (+351) 21 391 15 96 (currently not available due to teleworking)

Alexandre Maurício
Tel: (+351) 21 391 76 48

This project receives funding from the European Union's Horizon 2020 research and innovation programme under grant agreement no. 825664.